Skip to main content
. 2020 May 13;9(1):1756130. doi: 10.1080/2162402X.2020.1756130

Figure 3.

Figure 3.

Serum concentrations of HSP90α in patients with non-thymomatous MG. The serum differences of HSP90α in patients with non-thymomatous MG, TET(MG+), TET (MG) and healthy volunteers are shown (a). Further analysis of non-thymomatous MG patients according to the detection of antibodies to acetylcholine receptor antibodies (seropositive vs. seronegative is depicted (b). Moreover, the analysis of pHSP27 serum concentrations in patients with non-thymomatous MG receiving treatment with steroids is shown (c). The HSP90α serum concentration in patients improved after thymectomy and those who did not respond properly is depicted (d).